<html><head><title>EC 1.14.13.181</title></head><base href="http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/14/13/181.html"><body><center><b>IUBMB Enzyme Nomenclature</b><p><h1><b>EC 1.14.13.181</b></h1></center><b>Accepted name:</b> 13-deoxydaunorubicin hydroxylase<p><b>Reaction:</b>   (1) 13-deoxydaunorubicin + NADPH + H<small><sup>+</sup></small> + O<small><sub>2</sub></small> = 13-dihydrodaunorubicin + NADP<small><sup>+</sup></small> + H<small><sub>2</sub></small>O<br> (2) 13-dihydrodaunorubicin + NADPH + H<small><sup>+</sup></small> + O<small><sub>2</sub></small> = daunorubicin + NADP<small><sup>+</sup></small> + <b>2</b> H<small><sub>2</sub></small>O<p>For diagram of reaction <a href="../../../reaction/phenol/daunorub.html">click here</a>.<p><b>Glossary:</b> 13-dihydrodaunorubicin = daunorubicinol = (1<i>S</i>,3<i>S</i>)-3,5,12-trihydroxy-3-(1-hydroxyethyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-&alpha;-<small>L</small>-<i>lyxo-</i>hexopyranoside<br>13-deoxydaunorubicin = (1<i>S</i>,3<i>S</i>)-3-ethyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-&alpha;-<small>L</small>-<i>lyxo-</i>hexopyranoside<br>daunorubicin = (1<i>S</i>,3<i>S</i>)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-&alpha;-<small>L</small>-<i>lyxo-</i>hexopyranoside<p><b>Other name(s):</b> DoxA<p><b>Systematic name:</b> 13-deoxydaunorubicin,NADPH:oxygen oxidoreductase (13-hydroxylating)<p><b>Comments:</b> The enzymes from the Gram-positive bacteria <i>Streptomyces</i> sp. C5 and <i>Streptomyces peucetius</i> show broad substrate specificity for structures based on an anthracycline aglycone, but have a strong preference for 4-methoxy anthracycline intermediates (13-deoxydaunorubicin and 13-dihydrodaunorubicin) over their 4-hydroxy analogues (13-deoxycarminomycin and 13-dihydrocarminomycin), as well as a preference for substrates hydroxylated at the C-13 rather than the C-14 position. <p><b>Links to other databases:</b> <a href="http://www.brenda-enzymes.org/enzyme.php?ecno=1.14.13.181" target="new">BRENDA</a>, <a href="http://enzyme.expasy.org/EC/1.14.13.181" target="new">EXPASY</a>, <a href="http://www.genome.ad.jp/dbget-bin/www_bget?ec:1.14.13.181" target="new">KEGG</a>,<a href="http://www.metacyc.org/META/NEW-IMAGE?type=EC-NUMBER&object=EC-1.14.13.181" target="new">Metacyc</a>,CAS registry number: <p><b>References:</b><p>1. Walczak, R.J., Dickens, M.L., Priestley, N.D. and Strohl, W.R. Purification, properties, and characterization of recombinant <i>Streptomyces</i> sp. strain C5 DoxA, a cytochrome <i>P-</i>450 catalyzing multiple steps in doxorubicin biosynthesis. <i>J. Bacteriol.</i> 181 (1999) 298-304. [PMID: <a href="http://www.ncbi.nlm.nih.gov/pubmed/9864343?dopt=Abstract" target="new">9864343</a>]<p>2. Dickens, M.L., Priestley, N.D. and Strohl, W.R. <i>In vivo</i> and <i>in vitro</i> bioconversion of &epsilon;-rhodomycinone glycoside to doxorubicin: functions of DauP, DauK, and DoxA. <i>J. Bacteriol.</i> 179 (1997) 2641-2650. [PMID: <a href="http://www.ncbi.nlm.nih.gov/pubmed/9098063?dopt=Abstract" target="new">9098063</a>]<p><center><small>[EC 1.14.13.181 created 2013]</small></center><p><hr>Return to <a href="../13/">EC 1.14.13 home page</a><br>Return to <a href="../">EC 1.14 home page</a><br>Return to <a href="../../">EC 1 home page</a><br>Return to <a href="../../../">Enzymes home page</a><br>Return to <a href="../../../../">IUBMB Biochemical Nomenclature home page</a><p></body></html>